Biocept (BIOC) Reports Q2 Loss of $0.21/Share

Biocept (NASDAQ: BIOC) reported Q2 EPS of ($0.21), versus ($0.60) reported last year. Revenue for the quarter came in at $1.3 million, versus $663 thousand reported last year.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49